Factors that influence parental satisfaction with SDF treatment in healthy children and those with special healthcare needs od Y. O. Crystal, J. H. Jang, M. N. Janal, V. H. Raveis

Preuzmi cijeli tekst

The Prognostic Role of Pre-Treatment Neutrophil-to-Lymphocyte Ratio in an Asian Cohort of Patients with Oropharyngeal Squamous Cell Carcinoma od Isabelle J. H. Jang, Hanis B. Abdul Kadir, Kok Hing Lim, Wen Chao Daniel Chew, Jacqueline S. G. Hwang, Chwee Ming Lim

Preuzmi cijeli tekst

P829: A PHASE III RANDOMIZED CLINICAL TRIAL COMPARING SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) WITH REFERENCE ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA od J. H. Jang, R. Demichelis Gomez, H. Bumbea, L. Nogaieva, L. L. L. Wong, S. M. Lim, J. Park, Y. Kim, S. Cho

Preuzmi cijeli tekst

Construction of Yemilab od K. S. Park, Y. D. Kim, Y. D. Kim, K. M. Bang, H. K. Park, M. H. Lee, M. H. Lee, J. So, S. H. Kim, J. H. Jang, J. H. Kim, S. B. Kim

Preuzmi cijeli tekst

P827: EFFICACY AND SAFETY OF ROMIPLOSTIM ADDED TO IMMUNOSUPPRESSIVE THERAPY AS A FIRST-LINE TREATMENT IN PATIENTS WITH APLASTIC ANEMIA: A PHASE 2/3 CLINICAL TRIAL od H. Yamazaki, J. W. Lee, J. H. Jang, M. Sawa, M. Kizaki, Y. Tomiyama, K. Nagafuji, K. Usuki, J.-P. Gau, Y. Morita, J.-L. Tang, H. Chang, M. Noshiro, A. Matsuda, K. Ozawa, K. Mitani, Y. Kanda, S. Nakao

Preuzmi cijeli tekst

P498: CLINICAL AND BIOLOGICAL MARKERS ASSOCIATED WITH LONG-TERM SURVIVAL FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN REMISSION AFTER CHEMOTHERAPY IN THE QUAZAR AML-001 TRIAL... od A. H. Wei, H. Döhner, H. Sayar, F. Ravandi, P. Montesinos, H. Dombret, D. Selleslag, K. Porkka, J.-H. Jang, B. Skikne, C. Beach, T. Prebet, G. Zhang, A. Risueño, M. Ugidos Guerrero, W. L. See, D. Menezes, G. J. Roboz

Preuzmi cijeli tekst